Related Experiment Video
Updated: Jun 19, 2025
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies
Dimitris Kounatidis1, Nikolaos Tentolouris1, Natalia G Vallianou2
1Diabetes Center, First Department of Propaedeutic Internal Medicine, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Insights
Lipid-lowering therapies, primarily statins, reduce cardiovascular risk by improving lipid profiles. These treatments also offer additional health benefits, known as pleiotropic effects, impacting inflammation and vascular health.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Atherosclerotic cardiovascular disease (ASCVD) is a leading global health concern.
- Dyslipidemia is a primary modifiable risk factor for ASCVD.
- Lipid-lowering therapies, particularly statins, are central to managing cardiovascular risk.
Purpose of the Study:
- To review the pleiotropic effects of lipid-modifying therapies beyond their lipid-lowering capabilities.
- To explore the non-lipid-mediated benefits of these agents in cardiovascular and non-cardiovascular conditions.
- To discuss the mechanistic underpinnings and therapeutic potential of these diverse actions.
Main Methods:
- This is a narrative review synthesizing existing research.
- Literature search focused on lipid-modifying agents, their pleiotropic actions, and clinical implications.
- Analysis of studies examining anti-inflammatory, vascular, metabolic, and oncologic effects.
Main Results:
- Lipid-lowering therapies demonstrate significant pleiotropic effects, including anti-inflammatory and vascular benefits.
- These non-lipid effects contribute to cardiovascular risk reduction.
- Emerging evidence suggests benefits for non-cardiovascular conditions, such as cancer management.
Conclusions:
- Lipid-modifying therapies offer multifaceted benefits extending beyond lipid reduction.
- Understanding these pleiotropic actions is crucial for optimizing therapeutic strategies.
- Further research into these non-lipid effects may reveal novel applications for cardiovascular and other diseases.
Abstract:
Atherosclerotic cardiovascular disease poses a significant global health issue, with dyslipidemia standing out as a major risk factor. In recent decades, lipid-lowering therapies have evolved significantly, with statins emerging as the cornerstone treatment. These interventions play a crucial role in both primary and secondary prevention by effectively reducing cardiovascular risk through lipid profile enhancements. Beyond their primary lipid-lowering effects, extensive research indicates that these therapies exhibit pleiotropic actions, offering additional health benefits. These include anti-inflammatory properties, improvements in vascular health and glucose metabolism, and potential implications in cancer management. While statins and ezetimibe have been extensively studied, newer lipid-lowering agents also demonstrate similar pleiotropic effects, even in the absence of direct cardiovascular benefits. This narrative review explores the diverse pleiotropic properties of lipid-modifying therapies, emphasizing their non-lipid effects that contribute to reducing cardiovascular burden and exploring emerging benefits for non-cardiovascular conditions. Mechanistic insights into these actions are discussed alongside their potential therapeutic implications.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:29Cholesterol: Significance and Regulation
Considering cholesterol and...
01:31Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
01:24Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:24Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...